Keyword: Baylor College of Medicine
A multi-institution research team has made several surprising discoveries about the role of proteins in colon cancer, which could inspire new treatments.
The week’s biotech news included an eFFECTOR drug that slows liver cancer in mice and insight into age-related muscle decline.
Diagnostic maker Echosens is teaming up with a consortium of health systems to develop a real-world evidence model to help standardize care for NASH.
Last week’s biotech discoveries include a gut-coating pill that lowers glucose and prostate-tumor test to predict a good response to immunotherapy.
The agreement will give TapImmune control of adoptive T-cell therapies designed to provide more durable responses than CAR-Ts.
The past week ushered in news about a toxin in scorpion venom that may relieve RA and a skin bacterium with anti-cancer powers.
CRISPR is a promising treatment for blood disorders, but it comes with challenges, such as off-target effects.
Scientists at Baylor have discovered that when they silence a signaling pathway in the body called Hippo, they can reverse heart failure in mice.
A new target for the treatment of MeCP2 duplication syndrome could be useful in treating autism and other neurological conditions.
Normalizing the blood vessels that feed tumors and gaining a better understanding of how they interact with immune cells could improve cancer treatment, Baylor researchers report.